The balance between pro-apoptotic and anti-apoptotic pathways in the failing myocardium.
The purpose of this review is to highlight those circulating molecules, membrane receptors, and signaling pathways that initiate, potentiate, or conversely, inhibit apoptosis within cardiomyocytes. This review focuses on pathways directly related to the failing heart and discusses the limitations of current methodologies for assessing cardiomyocellular apoptosis. It is important to note that the adrenergic, reactive oxygen species, and proinflammatory cytokine signaling pathways are not the only pro-apoptotic pathways active in the myocardium, nor are IL-6-related cytokine, calcineurin, and IGF-1/PI3K/Akt signaling pathways the only anti-apoptotic pathways active in the myocardium. However, they are among the best-characterized apoptosis-mediating pathways and therefore they may serve as foundation for future studies aimed at identifying novel apoptotic regulating pathways active in cardiomyocytes. Considering the short history of studying cardiomyocellular apoptosis, a tremendous body of knowledge has been collected. Understandably, much more work remains. Tomorrow's studies must (1) continue to examine the signaling pathways mediating cardiomyocellular apoptosis by focusing on the links to the ubiquitous apoptosis effectors, (2) use the expanding body of knowledge to develop more specific inhibitors of apoptosis, and then (3) confirm the causal relationship of cardiomyocellular apoptosis and cardiac dysfunction in physiologic models of cardiac challenge.
McGowan
Brian S
BS
Thomas Jefferson University, Center for Translational Medicine and Functional Genomics, Philadelphia, PA 19107, USA. brianmcgowan@usa.net
Ciccimaro
Eugene F
EF
Chan
Tung O
TO
Feldman
Arthur M
AM
D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D019703:Calcineurin / Q000502:physiology; D009202:Cardiomyopathies / Q000473:pathology; D016207:Cytokines / Q000502:physiology; D006333:Heart Failure / Q000473:pathology* / Q000503:physiopathology; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000502:physiology; D015850:Interleukin-6 / Q000502:physiology; D019869:Phosphatidylinositol 3-Kinases / Q000502:physiology; D017382:Reactive Oxygen Species / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*; D013564:Sympathetic Nervous System / Q000503:physiopathology
D016207:Cytokines; D015850:Interleukin-6; D017382:Reactive Oxygen Species; D007334:Insulin-Like Growth Factor I; D019869:Phosphatidylinositol 3-Kinases; D019703:Calcineurin